Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rachel E, Barnett"'
Autor:
Rachel C. Blitzblau, Alessandro D. Santin, Marta Boeke, Renata A. Tassi, Frank J. Slack, Ellen T. Matloff, Elena Ratner, Joanne B. Weidhaas, Daniel Zelterman, Sunitha Nallur, Lingeng Lu, Herbert Yu, Harvey A. Risch, Trupti Paranjape, Pei Hui, Thomas J. Rutherford, Peter J. Schwartz, Cory Pelletier, Lena J. Chin, Andrew K. Godwin, Rachel E. Barnett
Publikováno v:
Cancer Research. 70:6509-6515
Ovarian cancer (OC) is the single most deadly form of women's cancer, typically presenting as an advanced disease at diagnosis in part due to a lack of known risk factors or genetic markers of risk. The KRAS oncogene and altered levels of the microRN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65446f0f26048c7b30042d6a0efc9b3e
https://doi.org/10.1158/0008-5472.can-10-0689
https://doi.org/10.1158/0008-5472.can-10-0689
Publikováno v:
Journal of Genetic Counseling. 27:1523-1523
The original article [1] was initially published with the following list of authors: Allison Werner-Lin, Shana L. Merrill, and Amanda C. Brandt. This author list is now corrected as follows: Allison Werner-Lin, Shana L. Merrill, Amanda C. Brandt, Rac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99fead9d8ec7099ef02688fffebf8870
https://doi.org/10.1007/s10897-018-0282-0
https://doi.org/10.1007/s10897-018-0282-0
Autor:
Danielle C, Bonadies, Karina L, Brierley, Rachel E, Barnett, Melanie D, Baxter, Talia, Donenberg, Whitney L, Ducaine, Michelle E, Ernst, Michelle E, Ernstx, Jeanne, Homer, Megan, Judkins, Niki M, Lovick, Jacquelyn M, Powers, Christine, Stanislaw, Elizabeth, Stark, Rio C, Stenner, Ellen T, Matloff
Publikováno v:
Cancer journal (Sudbury, Mass.). 20(4)
After repeated media attention in 2013 due to the Angelina Jolie disclosure and the Supreme Court decision to ban gene patents, the demand for cancer genetic counseling and testing services has never been greater. Debate has arisen regarding who shou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faba111d139108d6f3e8faf24a017ddc
https://pubmed.ncbi.nlm.nih.gov/25098283
https://pubmed.ncbi.nlm.nih.gov/25098283
Publikováno v:
Cancer journal (Sudbury, Mass.). 15(1)
Clinical genetic testing for BRCA1 and BRCA2 has become available in the past 15 years, and it has been established that female BRCA carriers have a high lifetime risk to develop both breast and ovarian cancer. Predisposition testing makes it possibl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104c9278829d13bc54b21846a6865c89
https://pubmed.ncbi.nlm.nih.gov/19197168
https://pubmed.ncbi.nlm.nih.gov/19197168